Jan Harder
Impact in
- Epidemiology top 1%
- Neuroendocrine Tumor Research Advances
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
Papers in
- Co-authors
- Peter Josef Barth (1 shared paper)Ulrich‐Frank Pape (1 shared paper)Thomas Mathias Gress (1 shared paper)Christina Mayer (1 shared paper)Carmen Schade‐Brittinger (1 shared paper)Hans‐Helge Müller (1 shared paper)Anja Rinke (1 shared paper)Michael Bläker (1 shared paper)
- Journals
- British Journal of Cancer (4 papers)Journal of Clinical Oncology (2 papers)World Journal of Gastroenterology (2 papers)Journal of Vascular and Interventional Radiology (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Jan Harder
25 papers receiving 3.2k citations
Jan Harder's Hit Papers
Peers
Comparison fields: 5 of 57
- Epidemiology 1.7k
- Oncology 351
- Surgery 354
- Hepatology 65
- Hematology 45
Countries citing papers authored by Jan Harder
This map shows the geographic impact of Jan Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Harder more than expected).
Fields of papers citing papers by Jan Harder
This network shows the impact of papers produced by Jan Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Harder. The network helps show where Jan Harder may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Harder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group Hit paper breakdown → | 2009 | 1988 |
| 2 | 2007 | 262 | |
| 3 | 2012 | 162 | |
| 4 | 2006 | 107 | |
| 5 | 2009 | 106 | |
| 6 | 2012 | 104 | |
| 7 | 2009 | 79 | |
| 8 | 2012 | 73 | |
| 9 | 2011 | 67 | |
| 10 | 2008 | 53 | |
| 11 | 2010 | 43 | |
| 12 | 2011 | 41 | |
| 13 | 2007 | 38 | |
| 14 | 2010 | 36 | |
| 15 | 2009 | 22 | |
| 16 | 2015 | 22 | |
| 17 | 2004 | 14 | |
| 18 | 2004 | 14 | |
| 19 | 2009 | 14 | |
| 20 | 2014 | 10 |
About Jan Harder
Jan Harder is a scholar working on Oncology, Surgery, Hepatology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Pancreatic and Hepatic Oncology Research (5 papers), Epigenetics and DNA Methylation (2 papers), Telomeres, Telomerase, and Senescence (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Hepatitis C virus research (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Epidemiology (1.7k citations), Oncology (351 citations), Surgery (354 citations), Hepatology (65 citations) and Hematology (45 citations). Jan Harder has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Peter Josef Barth, Ulrich‐Frank Pape, Thomas Mathias Gress, Christina Mayer, Carmen Schade‐Brittinger, Hans‐Helge Müller, Anja Rinke, Michael Bläker, Behnaz Aminossadati and M. Wied. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, World Journal of Gastroenterology, Journal of Vascular and Interventional Radiology and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.